n-acetylsphingosine has been researched along with pyrazolanthrone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endoh, D; Hamasu, T; Hayashi, M; Kawana, A; Matsumoto, M; Okui, T | 1 |
| Charpentier, E; El Btaouri, H; Greffe, Y; Martiny, L; Morjani, H | 1 |
| Deng, Z; Du, WW; Fang, L; Jeyapalan, Z; Seth, A; Shan, SW; Yang, BB; Yang, BL; Yee, AJ; Zhang, Y | 1 |
3 other study(ies) available for n-acetylsphingosine and pyrazolanthrone
| Article | Year |
|---|---|
High sensitivity of fibroblast cell lines derived from LEC rats to heat treatment.
Topics: Animals; Anthracenes; Apoptosis; Cell Line; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Hot Temperature; HSP70 Heat-Shock Proteins; Imidazoles; Immunoblotting; Pyridines; Rats; Rats, Inbred LEC; Sphingosine; Time Factors | 2004 |
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells.
Topics: Activating Transcription Factor 2; Anthracenes; Apoptosis; Camptothecin; Caspase 3; Cell Line, Tumor; Cell Survival; Doxorubicin; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Sphingosine; Thrombospondin 1; Thyroid Neoplasms | 2011 |
Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Green Fluorescent Proteins; Humans; Mice; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sphingosine; Taxoids; Tyrphostins; Versicans | 2011 |